Log in to search using one of your social media accounts:


OCT Screening Cost-effective for Diabetic Retinopathy OCT Screening Cost-effective for Diabetic Retinopathy

It might make sense to screen everyone with diabetes for retinopathy using optical coherence tomography (OCT), new research suggests.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Related Links:

Conclusion: EX-PRESS filtration device has a good IOP-lowering effect and a low rate of complications in patients with advanced NVG associated with PDR. In addition, there was no loss of light perception or no line decrease of the BCVA.Case Rep Ophthalmol 2018;9:61 –69
Source: Case Reports in Ophthalmology - Category: Opthalmology Source Type: research
Abstract AimsTo report the findings on weight loss after the first year of the lifestyle intervention trial among women with gestational diabetes mellitus (GDM). MethodsA total of 1180 GDM women were randomly assigned (1:1) to receive a 4‐year lifestyle intervention (intervention group, n=586) or standard care (control group, n=594) between August 2009 and July, 2011. Major elements of the intervention included six face‐to‐face sessions with study dietitians and two telephone calls in the first year, and two individual sessions and two telephone calls in each subsequent year. ResultsAmong 79% of participants who comp...
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Tags: ORIGINAL ARTICLE Source Type: research
The University of Central Florida would create 302 high-wage jobs if it is selected to take over the  Sanford Burnham Prebys Medical Discovery Institute's facility. The medical institute opened in Lake Nona's Medical City roughly 10 years ago. That location of the La Jolla, Calif.-based nonprofit medical research institute focused on research in obesity-related diabetes and its cardiovascular co mplications. In 2006, the state approved more than $155 million to incentivize the institute's expansion…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Juice is the health trend that just won’t go away. There’s a juicing shop on practically every city block, and everyone from your Spin instructor to your mother downs glasses of it daily. There’s no doubt that juicing is ubiquitous—but is it as healthy as everyone says? Juice can help you consume more vitamins and minerals, and that’s a positive for people who struggle to eat enough fruits and vegetables. But experts say it may not deserve its health halo. In a paper published last winter in the Journal of the American College of Cardiology, experts scrutinized several nutrition-hyped foods&md...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Diet/Nutrition green juice healthytime juice cleanse Juicing onetime smoothies Weight loss Source Type: news
Findings demonstrate an important population burden, including hospitalization and death
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Oncology, Orthopedics, Pathology, Pediatrics, Pulmonology, Surgery, Journal, Source Type: news
Sufficient studies strongly link gestational diabetes to CVD, and targeting this subgroup of women for prevention will, at the very least, reduce the number converting to type 2 diabetes.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news
Nemaura Medical (OTC:NMRD) said today that shares of its common stock were approved to list on the NASDAQ exchange. The medtech company’s shares are slated to start trading on Jan. 25 under its existing symbol. Get the full story at our sister site, Drug Delivery Business News. The post Nemaura uplists shares to NASDAQ exchange appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Patient Monitoring Wall Street Beat Nemaura Medical Source Type: news
Long-term metformin given to women with PCOS improved menstrual cycle regularity and hormone profiles in normal and overweight women; however, there were differences in response by testosterone status.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Four new studies were published in this month’s issue of the Journal of Diabetes Science and Technology touting patient outcomes linked to Glytec‘s eGlycemic diabetes management system, the company reported. In both inpatient and outpatient settings, the use of eGMS for insulin therapy management was safer and more effective than traditional standards of care. The studies reported lower rates of hypoglycemia, quicker time to target glucose levels, sustained reductions in A1c levels and faster resolution of diabetic ketoacidosis associated with Glytec’s system. Get the full story at our sist...
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Drug-Device Combinations Hospital Care Pharmaceuticals Software / IT Glytec Source Type: news
GI Dynamics (ASX:GID) said yesterday it raised approximately $1.6 million (AUD $2 million) in a private placement of Australian CHESS depository interests looking to support continued development of its EndoBarrier and for general working capital. The Boston-based company said the placement comes through the sale of approximately 58.8 million CDIs, representing 1.2 million shares of common stock at 28¢ (AUD 35¢) per share in two tranches. The first tranche, which closed today, consists of 28.5 million CDIs, representing 569,341 shares of common stock and raising $779,442 (AUD $996,347), GI Dynamics said...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Wall Street Beat GI Dynamics Source Type: news
More News: Diabetes | Endocrinology | Health